Literature DB >> 18688621

Local recurrence after curative resection in patients with colon and rectal cancers.

H R Yun1, L J Lee, J H Park, Y K Cho, Y B Cho, W Y Lee, H C Kim, H K Chun, S H Yun.   

Abstract

BACKGROUND AND AIMS: There are a range of rates and a number of prognostic factors associated with the local recurrence of colorectal cancer after curative resection. The aim of this study was to identify the potential prognostic factors of local recurrence in patients with colon and rectal cancers.
MATERIALS AND METHODS: A retrospective review of 1,838 patients who underwent curative resection of non-metastatic colorectal cancer was conducted. The patients were treated between 1994 and 2004, and had a minimum follow-up of 3 years.
RESULTS: There were 994 patients with colon cancer and 844 patients with rectal cancer. The median duration of follow-up was 60.9 +/- 24.5 months. With respect to colon cancer, the local recurrence rate was 6.1% (61 patients). With respect to rectal cancer, 95 patients had a local recurrence (11.3%), the rate of which was statistically greater than the local recurrence rate for colon cancer (p < 0.001). The overall recurrence rate was 16.4% (301 patients), and the local recurrence rate, with or without systemic metastases, was 8.5% (156 patients). Local recurrences occurred within 2 and 3 years in 59.9% and 82.4% of the patients, respectively. In patients with colon and rectal cancer, the pathologic T stage (p = 0.044 and p = 0.034, respectively), pathologic N stage (p = 0.001 and p < 0.001, respectively), and lymphovascular invasion (p = 0.013 and p = 0.004, respectively) were adverse risk factors for local recurrence. The level of the anastomosis from the anal verge was an additional prognostic factor (p = 0.007) in patients with rectal cancer.
CONCLUSION: Compulsive follow-up care of patients with colon and rectal cancers is needed for 3 years after curative resection, especially in patients who have adverse risk factors for local recurrence.

Entities:  

Mesh:

Year:  2008        PMID: 18688621     DOI: 10.1007/s00384-008-0530-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  34 in total

1.  Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients.

Authors:  L E Harrison; J G Guillem; P Paty; A M Cohen
Journal:  J Am Coll Surg       Date:  1997-07       Impact factor: 6.113

2.  Population-based study of prognostic factors in stage II colonic cancer.

Authors:  M Morris; C Platell; B de Boer; K McCaul; B Iacopetta
Journal:  Br J Surg       Date:  2006-07       Impact factor: 6.939

3.  Risk factors and clinical outcome for anastomotic leakage after total mesorectal excision for rectal cancer.

Authors:  Won-Suk Lee; Seong Hyeon Yun; Young-Nam Roh; Hae-Ran Yun; Woo Yong Lee; Yong Beom Cho; Ho-Kyung Chun
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

4.  Colon cancer management and outcome in relation to individual hospitals in a defined population.

Authors:  A Sjövall; T Holm; T Singnomklao; F Granath; B Glimelius; B Cedermark
Journal:  Br J Surg       Date:  2007-04       Impact factor: 6.939

5.  Outcome of colorectal cancer.

Authors:  M Pescatori; C Mattana; G Maria; A Ferrara; L Lucibello
Journal:  Br J Surg       Date:  1987-05       Impact factor: 6.939

6.  Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture.

Authors:  R K Phillips; R Hittinger; L Blesovsky; J S Fry; L P Fielding
Journal:  Br J Surg       Date:  1984-01       Impact factor: 6.939

7.  Impact of anastomotic leakage on oncological outcome after rectal cancer resection.

Authors:  H Ptok; F Marusch; F Meyer; D Schubert; I Gastinger; H Lippert
Journal:  Br J Surg       Date:  2007-12       Impact factor: 6.939

8.  Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon.

Authors:  Thomas E Read; Matthew G Mutch; Benjamin W Chang; Michael S McNevin; James W Fleshman; Elisa H Birnbaum; Robert D Fry; Philip F Caushaj; Ira J Kodner
Journal:  J Am Coll Surg       Date:  2002-07       Impact factor: 6.113

9.  Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum.

Authors:  R M Olson; N P Perencevich; A W Malcolm; J T Chaffey; R E Wilson
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

10.  Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum.

Authors:  A W Malcolm; N P Perencevich; R M Olson; J A Hanley; J T Chaffey; R E Wilson
Journal:  Surg Gynecol Obstet       Date:  1981-02
View more
  17 in total

Review 1.  Complete Mesocolic Excision and D3 Lymphadenectomy versus Conventional Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis.

Authors:  Tamara Díaz-Vico; María Fernández-Hevia; Aida Suárez-Sánchez; Carmen García-Gutiérrez; Luka Mihic-Góngora; Daniel Fernández-Martínez; José Antonio Álvarez-Pérez; Jorge Luis Otero-Díez; José Electo Granero-Trancón; Luis Joaquín García-Flórez
Journal:  Ann Surg Oncol       Date:  2021-06-04       Impact factor: 5.344

2.  Long-term surveillance of locally advanced rectal cancer patients with neoadjuvant chemoradiation and aggressive surgical treatment of recurrent disease: a consecutive single-centre experience.

Authors:  Matthias Zitt; Alexander DeVries; Josef Thaler; Reinhold Kafka-Ritsch; Wolfgang Eisterer; Peter Lukas; Dietmar Öfner
Journal:  Int J Colorectal Dis       Date:  2015-08-21       Impact factor: 2.571

3.  Development of the 'PREDICT' score through a systematic review and meta-analysis of the predictive parameters for locoregional recurrence after total mesorectal excision.

Authors:  Sualeh Muslim Khan; Sameh Hany Emile; Samer Hani Barsom; Syed Osama Ahsan
Journal:  Updates Surg       Date:  2020-07-30

4.  Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy.

Authors:  Jae Young Kwak; Chan Wook Kim; Seok-Byung Lim; Chang Sik Yu; Tae Won Kim; Jong Hoon Kim; Se Jin Jang; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2012-08-10       Impact factor: 3.452

Review 5.  Extent of surgery in cancer of the colon: is more better?

Authors:  Wouter Willaert; Wim Ceelen
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

6.  Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer.

Authors:  Mehmet U S Ayvaci; Jinghua Shi; Oguzhan Alagoz; Sam J Lubner
Journal:  Med Decis Making       Date:  2013-01-11       Impact factor: 2.583

7.  Locally recurrent colorectal cancer: results of surgical therapy.

Authors:  M Kruschewski; M Ciurea; S Lipka; S Daum; L Moser; B Meyer; J Gröne; J Budczies; H J Buhr
Journal:  Langenbecks Arch Surg       Date:  2012-06-28       Impact factor: 3.445

8.  Clinical Pattern of Recurrent Disease during the Follow-Up of Rectal Carcinoma.

Authors:  Thijs Wieldraaijer; Pascal Bruin; Laura A M Duineveld; Pieter J Tanis; Anke B Smits; Henk C P M van Weert; Jan Wind
Journal:  Dig Surg       Date:  2017-03-14       Impact factor: 2.588

9.  Competing risk models to estimate the excess mortality and the first recurrent-event hazards.

Authors:  Aurélien Belot; Laurent Remontet; Guy Launoy; Valérie Jooste; Roch Giorgi
Journal:  BMC Med Res Methodol       Date:  2011-05-25       Impact factor: 4.615

10.  Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence?

Authors:  Jeonghyun Kang; Hyunki Kim; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Kang Young Lee; Seung Kook Sohn; Nam Kyu Kim
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.